Unconventional Secretion of PKCδ Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer
Open Access
- 15 January 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (2), 414-425
- https://doi.org/10.1158/0008-5472.can-20-2009
Abstract
Expression of human protein kinase C delta (PKCδ) protein has been linked to many types of cancers. PKCδ is known to be a multifunctional PKC family member and has been rigorously studied as an intracellular signaling molecule. Here we show that PKCδ is a secretory protein that regulates cell growth of liver cancer. Full-length PKCδ was secreted to the extracellular space in living liver cancer cells under normal cell culture conditions and in xenograft mouse models. Patients with liver cancer showed higher levels of serum PKCδ than patients with chronic hepatitis or liver cirrhosis or healthy individuals. In liver cancer cells, PKCδ secretion was executed in an endoplasmic reticulum (ER)-Golgi–independent manner, and the inactivation status of cytosolic PKCδ was required for its secretion. Furthermore, colocalization studies showed that extracellular PKCδ was anchored on the cell surface of liver cancer cells via association with glypican 3, a liver cancer–related heparan sulfate proteoglycan. Addition of exogenous PKCδ activated IGF-1 receptor (IGF1R) activation and subsequently enhanced activation of ERK1/2, which led to accelerated cell growth in liver cancer cells. Conversely, treatment with anti-PKCδ antibody attenuated activation of both IGF1R and ERK1/2 and reduced cell proliferation and spheroid formation of liver cancer cells and tumor growth in xenograft mouse models. This study demonstrates the presence of PKCδ at the extracellular space and the function of PKCδ as a growth factor and provides a rationale for the extracellular PKCδ-targeting therapy of liver cancer. PKCδ secretion from liver cancer cells behaves as a humoral growth factor that contributes to cell growth via activation of proliferative signaling molecules, which may be potential diagnostic or therapeutic targets.Other Versions
Funding Information
- Japan Society for the Promotion of Science (16K18434, 18K19484, 20K07621)
- Japan Society for the Promotion of Science (17H03584, 18K15253, 20H03519)
- Japan Society for the Promotion of Science (19K16781)
- AMED (B326TS)
This publication has 49 references indexed in Scilit:
- Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complexBlood, 2013
- Regulated Binding of Importin-α to Protein Kinase Cδ in Response to Apoptotic Signals Facilitates Nuclear ImportOnline Journal of Public Health Informatics, 2011
- Unconventional secretion: a stress on GRASPCurrent Opinion in Cell Biology, 2011
- Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cellsThe EMBO Journal, 2010
- Claudin-1 Acts through c-Abl-Protein Kinase Cδ (PKCδ) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver CellsJournal of Biological Chemistry, 2010
- Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN PathwayCancer Research, 2009
- Phorbol 12-Myristate 13-Acetate-dependent Protein Kinase Cδ-Tyr311 Phosphorylation in Cardiomyocyte CaveolaeOnline Journal of Public Health Informatics, 2008
- Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathwayCarcinogenesis: Integrative Cancer Research, 2008
- Protein Kinase Cɛ (PKCɛ) and Src Control PKCδ Activation Loop Phosphorylation in CardiomyocytesOnline Journal of Public Health Informatics, 2007
- Intracellular Aspects of the Process of Protein SynthesisScience, 1975